Quinn Opportunity Partners LLC Bio N Tech Se Transaction History

Quinn Opportunity Partners LLC

$1.08 Billion
Q2 2025

A detailed history of Quinn Opportunity Partners LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 25,075 shares of BNTX stock, worth $2.78 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

25,075

Previous 197,946 87.33%

Holding current value

$2.78 Million

Previous $18 Million 85.19%

% of portfolio

0.25%

Previous 1.35%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$86.65 - $120.54 $15 Million - $20.8 Million	-172,871 Reduced 87.33%	25,075 $2.67 Million
Q1 2025 May 14, 2025	SELL	$91.06 - $126.88 $14.4 Million - $20.1 Million	-158,248 Reduced 44.43%	197,946 $18 Million
Q4 2024 Feb 13, 2025	SELL	$99.72 - $122.68 $4.82 Million - $5.93 Million	-48,306 Reduced 11.94%	356,194 $40.6 Million
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $21.8 Million - $34.8 Million	-278,787 Reduced 40.8%	404,500 $48 Million
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $2.42 Million - $3.1 Million	-30,096 Reduced 4.22%	683,287 $54.9 Million
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $3.45 Million - $4.36 Million	38,800 Added 5.75%	713,383 $65.8 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $1.38 Million - $1.71 Million	15,200 Added 2.31%	674,583 $71.2 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $24.6 Million - $31.2 Million	249,768 Added 60.98%	659,383 $71.6 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $6.32 Million - $7.99 Million	61,650 Added 17.72%	409,615 $44.2 Million
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $10.5 Million - $13.2 Million	85,894 Added 32.78%	347,965 $43.3 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $31 Million - $48.8 Million	262,071 New	262,071 $39.4 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $3.91 Million - $5.61 Million	-30,664 Reduced 10.2%	270,057 $36.4 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $12.5 Million - $18.9 Million	-101,518 Reduced 25.24%	300,721 $44.8 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $43.6 Million - $80 Million	345,049 Added 603.34%	402,239 $68.6 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $12 Million - $20 Million	55,190 Added 2759.5%	57,190 $14.7 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $5.15 Million - $11.2 Million	-25,000 Reduced 92.59%	2,000 $546,000
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $5.83 Million - $12.4 Million	-51,460 Reduced 65.59%	27,000 $6.05 Million
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $5.91 Million - $8.24 Million	68,960 Added 725.89%	78,460 $8.57 Million
Q4 2020 Feb 11, 2021	BUY	$72.71 - $129.54 $690,744 - $1.23 Million	9,500 New	9,500 $774,000

Others Institutions Holding BNTX

# of Institutions

317

Shares Held

40.9M

Call Options Held

1.37M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.

Account

Quinn Opportunity Partners LLC Bio N Tech Se Transaction History